Biopharma Genomic Testing Market Research
Pharma & Biotech
30
Voice-of-Customer Research
Objective
A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx
Our Approach
Primary Research
- Conducted telephone interviews with biopharma stakeholders director level and above involved in oncology R&D (translational and clinical research)
- Conducted telephone interviews with biopharma CDx stakeholders director level and above (e.g., vice president of biomarker strategy)
- Interviews were split by biopharma size with a majority at large biopharma
Outcome
DeciBio delivered a virtual final presentation that covered an in depth quantitative market analysis (e.g., landscape today, key trends, and expected future growth)
Quantitative assessment included:
- Share of clinical trials employing prospective and / or retrospective genomic tests
- Frequency of tests (e.g., therapy selection, MRD, treatment response monitoring) per patient
- Test utilization by sample type, panel size, and (de)centralized models
Related Client Results
Diagnostic Advisory Board
Voice-of-Customer Research
KOL Identification
Synthetic mRNA Production Landscape Assessment
Voice-of-Customer Research
Competitive Analysis
Market Landscaping and Sizing
Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing
Customer Segmentation
Voice-of-Customer Research
Market Landscaping and Sizing